[1]
I. K. Q. . Al-Hasso, “Evaluation of Interleukin-22 and Toll-like receptor-2 as an Immunological Biomarkers in Breast Cancer Patients”, Al-Kindy Col. Med. J, vol. 20, no. 2, pp. 97–100, Aug. 2024, doi: 10.47723/3sfb2q82.